Journal
VACCINE
Volume 39, Issue 12, Pages 1701-1707Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2021.02.025
Keywords
Veterinary vaccine; Foot-and-mouth disease; Efficacy; Optimal age; One-shot; Two-shot; Vaccination
Categories
Funding
- Animal and Plant Quarantine Agency, Gimcheon, Gyeongsangbuk, Republic of Korea
Ask authors/readers for more resources
The study evaluated the in vivo efficacy of two type O commercial vaccines against a heterologous virus challenge in pigs. The optimal age for primary vaccination with these vaccines was found to be 8 weeks, demonstrating a significant protective effect.
Two type O commercial vaccines, the O-1/Campos and O/Primorsky/2014 vaccines, were studied to evaluate the in vivo efficacy in pigs against heterologous virus challenge with the O/SKR/Jincheon/2014 virus (O/SEA/Mya-98 lineage) isolated in Korea in 2014. The in vivo challenge results indicated that both vaccines induced a high heterologous virus neutralization test (VNT) titer by a single injection and successfully protected specific pathogen-free (SPF) pigs from challenge infection. To determine the optimal vaccination age, a field trial with each vaccine was conducted with three one-shot-vaccinated groups that were injected at 8, 12, or 14 weeks of age and one two-shot-vaccinated group that was injected at 8 and 12 weeks of age in the pig farms. In these field trials, the improved serological performance at 20 and 24 weeks of age expected with vaccination at 12 or 14 weeks of age was not observed, although improved serological results were expected as the result of decreasing interference of maternally derived antibodies (MDAs), as MDAs waned with age. In addition, delayed vaccination resulted in MDA depletion at 14 weeks of age. Therefore, the optimal age for primary vaccination with two different formulated vaccines was 8 weeks old in pigs, considering that MDAs could provide a protective immunity against foot-and-mouth disease (FMD) infection. Prolonged significantly higher VNT titers of immunized pigs were demonstrated in the two-shot-vaccinated groups. In total, the effectiveness of the two vaccines was demonstrated through efficacy tests and field trials in pigs. (C) 2021 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available